Cristian Rivera’s journey and determination inspired his father, John “Gungie” Rivera, to start the Cristian Rivera Foundation, a New York City-based 501(c)(3) not-for-profit organization, that is committed to finding a cure for Diffuse Intrinsic Pontine Glioma (DIPG) through education, program funding and family support. Our foundation strives to increase public awareness of DIPG, as well as raise funds that will provide financial support to families and medical facilities that conduct innovative research and clinical trials. Through its many efforts, the Cristian Rivera Foundation has helped build the foundation that supports the groundbreaking research that will one-day cure DIPG. The Cristian Rivera Foundation funds the work of Dr. Mark Souweidane, Director of Pediatric Neurosurgery of Weill Cornell Medical Center – Memorial Sloane (Kettering) Cancer Center and Dr. Oren Becher of Ann & Robert H. Lurie Children’s Hospital and the Lurie Cancer Center at Northwestern.
In 2012, Dr. Mark Souweidane, the Director of the Pediatric Brain and Spine Center at Weill Cornell Medical Center and Memorial Sloan Kettering, officially launched a pioneering clinical trial that would test the safety of a highly innovative approach using a small fiber to directly deliver drugs into the tumor. On May 1st, 2012, the date of his first official surgery, as part of the clinical trial, Dr. Souweidane said with pride, “Today, the first day of Brain Tumor Awareness Month… marks a day of hope for her family, an entry into a new treatment approach for these children, and the culmination of over 15 years of translational research.” This clinical trial has given hope to a handful of children. One of those children, Lisha Ayala, has seen no growth in her tumor and has responded well to Dr. Souweidane’s clinical trials. Lisha has lived with DIPG for 5 years, showing us that our work and dedication are paying off.
Complementing Dr. Souweidane’s amazing work is the enlightening research being performed at the Ann & Robert H. Lurie Children’s Hospital and the Lurie Cancer Center at Northwestern University lab of Dr. Oren Becher. The Cristian Rivera Foundation is proud to support Dr. Becher, helping him and his team to develop genetic models of DIPG to better understand the function of genetic alterations in DIPG formation, specifically the genetic alterations that are most important to inhibit therapeutically.
It is research like this that gives us hope that the Cristian Rivera Foundation’s dream of a world without DIPG will soon become a reality. The Cristian Rivera Foundation has pledged its support to Dr. Souweidane and Dr. Becher as they execute their important research and clinical trials.
To date, the Cristian Rivera Foundation has donated more than one million dollars ($1,000,000.00) to the respective doctors, as their work remains at the forefront of DIPG research. As a result of our hard work, The Cristian Rivera Foundation was awarded a Platinum Seal on GuideStar.org. GuideStar.org is the non-profit industry leader in analysis and public information and issues their rating based on transparency and the positive activity conducted in the non-profit community. Not only does our foundation have a Platinum Seal on GuideStar.org, The Cristian Rivera is also the recipient of the 2018 Top-Rated Great Nonprofits Award from Great Nonprofits. As you can see, our foundation takes pride in the work we do and we’re honored to have received such prestigious awards.
Help us continue this amazing work by participating in our 1st Annual Cristian Rivera Foundation 5K Walk/Run on Saturday, June 9th, 2018 at 9:00 a.m. We thank you for your continued support and look forward to eradicating our world of DIPG with your help.